title: [Which therapy in the acute stage of myocardial infarct is in position to prolong survival?].
authors.forename: M L
authors.initials: ML
authors.lastname: Colombo
authors.forename: G
authors.initials: G
authors.lastname: Specchia
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D009603:Nitroso Compounds / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D009603:Nitroso Compounds
vernacular_title: Quale terapia nella fase acuta dell'infarto miocardico è in grado di prolungare la sopravvivenza?